insights_auto
Why is NVSEF up 3,12%?
Dive Deeperchevron_right
NVSEF:OTCMKTS
Novartis AG
USD 139,98
arrow_upward
+3,12%(+4,23) 1D
9 Okt., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVSEF...
Open
USD 146,23
High
USD 146,23
Low
USD 139,98
Mkt. cap
288,81 mjd
Avg. vol.
30,92 k
Volume
581,00
52-wk high
USD 171,29
52-wk low
USD 120,00
Beta
0,40
Shares outstanding
2,03 mjd
No. of employees
75 k
Open
USD 146,23
High
USD 146,23
Low
USD 139,98
Mkt. cap
288,81 mjd
Avg. vol.
30,92 k
Volume
581,00
52-wk high
USD 171,29
52-wk low
USD 120,00
Beta
0,40
Shares outstanding
2,03 mjd
No. of employees
75 k
News stories
From web sources and news partners
AD HOC NEWS
·
19 uur gelede
Novartis stock trades at EUR 127.87 while volume is 21.5 percent below average
marketscreener.com
·
1 dag gelede
Swiss Market Index Retreats; Novartis Shares Decline
AD HOC NEWS
·
1 dag gelede
DKSH expands Novartis partnership and DKSH stock costs EUR 74.90
Reuters
·
2 dae gelede
AI companies run virtual drug trials, aim to improve success of human studies
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75,3 k
Founded07 Mrt. 1996
HeadquartersBasel, Basel City, Switserland
SectorPharmaceutical industry
Websitenovartis.com